Viewing Study NCT00040534


Ignite Creation Date: 2025-12-25 @ 2:36 AM
Ignite Modification Date: 2026-04-10 @ 4:31 AM
Study NCT ID: NCT00040534
Status: TERMINATED
Last Update Posted: 2015-02-16
First Post: 2002-06-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor in Combination With Gemcitabine and Cisplatin in Advanced Cancer (Study P01499)(TERMINATED)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module References Module